KRAS G12C inhibitor 16
KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 39, has an IC50 of 97 nM[1].
Product Specifications
CAS Number
2349392-79-4
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-16.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C2=C(C)C(N=CC3=C4N5[C@H](CN(C(C=C)=O)CC5)CO3)=C4C=C2Cl)C(F)=CC=C1
Molecular Formula
C24H21ClFN3O3
Molecular Weight
453.89
References & Citations
[1]Jason Grant Kettle, et al. Tetracyclic compounds as inhibitors of g12c mutant ras protein, for use as anti-cancer agents. WO2019110751A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940204-100 1x 100 µL
Complement C4d (C4D204), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470178-500 1x 500 µL
CD50 (ICAM-3) (186-2G9), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400821-500 1x 500 µL
Caldesmon, HMW (h-Caldesmon) (CALD1/820 + h-CALD), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940681-500 1x 500 µL
Human Kappa Light Chain (HP6053), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details